Topic: How To Invest

Q: Hi Pat, I would like your opinion on Veeva Systems. Thanks and regards.

Article Excerpt

A: Veeva Systems, $168.62, symbol VEEV on New York (Shares outstanding: 127.8 million; Market cap: $24.2 billion; www.veeva.com), is a provider of Internet-based customer relationship management (CRM) software for the life sciences industry. The San Francisco-headquartered company has more than 750 customers, ranging from large pharmaceutical firms to emerging biotechs. In September 2018, Veeva launched a cloud application (that lets users to access software through the web and store data files on remote servers) to help life sciences companies better manage their clinical study data. Veeva Vault Clinical Data Management System (CDMS) combines multiple tools in one app so that that drug developers can make faster and more informed decisions. In the three months ended April 30, 2019, the company’s overall revenue rose 25.1%, to $244.8 million from $195.5 million a year earlier. Excluding one-time items, Veeva made $78.7 million, or $0.50 a share, in the latest quarter. That was up 53.1% from $51.4 million, or $0.33 a share. The gain came…